Coronary Intervention Outcomes in Patients with Liver Cirrhosis
Song Peng Ang1, Jia Ee Chia2, Jose Iglesias3,4
1Department of Medicine, Rutgers Health/Community Medical Center, Toms River, NJ, USA. spa45@rutgers.edu.
Insights
Patients with liver cirrhosis undergoing coronary interventions face higher mortality and bleeding risks. Strategies like radial access and contrast minimization are crucial for managing these high-risk cardiac patients.
Area of Science:
- Cardiology
- Hepatology
- Interventional Cardiology
Background:
- Liver cirrhosis presents unique hemodynamic and coagulopathic challenges.
- Patients with cirrhosis and coronary artery disease (CAD) have increased risks during coronary procedures.
Purpose of the Study:
- To review outcomes of coronary interventions in patients with liver cirrhosis and CAD.
- To highlight clinical challenges and management considerations for this high-risk group.
Main Methods:
- Review of recent studies on percutaneous coronary intervention (PCI) in cirrhotic patients.
- Analysis of mortality, bleeding complications, and procedural risks.
Main Results:
- Cirrhotic patients undergoing PCI have higher mortality rates, especially with STEMI/NSTEMI.
- Coagulopathy and thrombocytopenia increase bleeding and vascular complication risks.
- Radial access, contrast minimization, and intravascular ultrasound (IVUS) are recommended strategies.
Conclusions:
- Managing CAD in cirrhotic patients requires tailored strategies due to unique pathophysiological states.
- Balancing thrombotic and bleeding risks is critical; IVUS and hydration show promise.
- Further research is needed to optimize treatment protocols for improved long-term outcomes.
Purpose Of Review:
This review assesses the outcomes of coronary interventions in patients with liver cirrhosis and coronary artery disease (CAD), focusing on the clinical challenges posed by cirrhosis-related hemodynamic and coagulopathic changes. It highlights essential considerations for managing these patients, who have an increased risk of adverse events during coronary procedures.
Recent Findings:
Recent studies have shown that patients with liver cirrhosis undergoing PCI experience significantly higher mortality rates compared to non-cirrhotic patients, particularly in the context of STEMI and NSTEMI. Coagulopathy and thrombocytopenia increase the risk of bleeding and vascular complications during interventions. Radial access has been suggested as a safer alternative to femoral access in these patients due to reduced bleeding complications. Additionally, contrast-induced nephropathy (CIN) is a prevalent risk, with cirrhotic patients demonstrating higher rates of acute kidney injury post-PCI. Preventive strategies such as minimizing contrast exposure and utilizing intravascular ultrasound (IVUS) are recommended. Managing CAD in cirrhotic patients requires careful consideration of their unique pathophysiological state. Higher in-hospital mortality, bleeding risks, and vascular complications necessitate tailored procedural strategies, such as radial access and contrast minimization. The balance between thrombotic and bleeding risks is critical in decision-making, with IVUS and hydration strategies being promising approaches. Further research is required to optimize treatment protocols and improve long-term outcomes for this high-risk population.
